ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities

Research output: Contribution to journalArticle

Radhika Nair, Wee Siang Teo, Vivek Mittal, Alexander Swarbrick

The inhibitor of differentiation (ID) proteins are helix-loop-helix transcriptional repressors with established roles in stem cell self-renewal, lineage commitment, and niche interactions. While deregulated expression of ID proteins in cancer was identified more than a decade ago, emerging evidence has revealed a central role for ID proteins in neoplastic progression of multiple tumor types that often mirrors their function in physiological stem and progenitor cells. ID proteins are required for the maintenance of cancer stem cells, self-renewal, and proliferation in a range of malignancies. Furthermore, ID proteins promote metastatic dissemination through their role in remodeling the tumor microenvironment and by promoting tumor-associated endothelial progenitor cell proliferation and mobilization. Here, we discuss the latest findings in this area and the clinical opportunities that they provide.

Original languageEnglish
Pages (from-to)1407-1415
Number of pages9
JournalMolecular Therapy
Volume22
Issue number8
DOIs
StatePublished - Jan 1 2014

PMID: 24827908

PMCID: PMC4435600

Altmetrics

Cite this

Standard

ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities. / Nair, Radhika; Teo, Wee Siang; Mittal, Vivek; Swarbrick, Alexander.

In: Molecular Therapy, Vol. 22, No. 8, 01.01.2014, p. 1407-1415.

Research output: Contribution to journalArticle

Harvard

Nair, R, Teo, WS, Mittal, V & Swarbrick, A 2014, 'ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities' Molecular Therapy, vol. 22, no. 8, pp. 1407-1415. https://doi.org/10.1038/mt.2014.83

APA

Nair, R., Teo, W. S., Mittal, V., & Swarbrick, A. (2014). ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities. Molecular Therapy, 22(8), 1407-1415. https://doi.org/10.1038/mt.2014.83

Vancouver

Nair R, Teo WS, Mittal V, Swarbrick A. ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities. Molecular Therapy. 2014 Jan 1;22(8):1407-1415. https://doi.org/10.1038/mt.2014.83

Author

Nair, Radhika ; Teo, Wee Siang ; Mittal, Vivek ; Swarbrick, Alexander. / ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities. In: Molecular Therapy. 2014 ; Vol. 22, No. 8. pp. 1407-1415.

BibTeX

@article{1ea57126bfcd44e19fd9bb280f788626,
title = "ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities",
abstract = "The inhibitor of differentiation (ID) proteins are helix-loop-helix transcriptional repressors with established roles in stem cell self-renewal, lineage commitment, and niche interactions. While deregulated expression of ID proteins in cancer was identified more than a decade ago, emerging evidence has revealed a central role for ID proteins in neoplastic progression of multiple tumor types that often mirrors their function in physiological stem and progenitor cells. ID proteins are required for the maintenance of cancer stem cells, self-renewal, and proliferation in a range of malignancies. Furthermore, ID proteins promote metastatic dissemination through their role in remodeling the tumor microenvironment and by promoting tumor-associated endothelial progenitor cell proliferation and mobilization. Here, we discuss the latest findings in this area and the clinical opportunities that they provide.",
author = "Radhika Nair and Teo, {Wee Siang} and Vivek Mittal and Alexander Swarbrick",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/mt.2014.83",
language = "English",
volume = "22",
pages = "1407--1415",
journal = "Molecular therapy : the journal of the American Society of Gene Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "8",

}

RIS

TY - JOUR

T1 - ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities

AU - Nair, Radhika

AU - Teo, Wee Siang

AU - Mittal, Vivek

AU - Swarbrick, Alexander

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The inhibitor of differentiation (ID) proteins are helix-loop-helix transcriptional repressors with established roles in stem cell self-renewal, lineage commitment, and niche interactions. While deregulated expression of ID proteins in cancer was identified more than a decade ago, emerging evidence has revealed a central role for ID proteins in neoplastic progression of multiple tumor types that often mirrors their function in physiological stem and progenitor cells. ID proteins are required for the maintenance of cancer stem cells, self-renewal, and proliferation in a range of malignancies. Furthermore, ID proteins promote metastatic dissemination through their role in remodeling the tumor microenvironment and by promoting tumor-associated endothelial progenitor cell proliferation and mobilization. Here, we discuss the latest findings in this area and the clinical opportunities that they provide.

AB - The inhibitor of differentiation (ID) proteins are helix-loop-helix transcriptional repressors with established roles in stem cell self-renewal, lineage commitment, and niche interactions. While deregulated expression of ID proteins in cancer was identified more than a decade ago, emerging evidence has revealed a central role for ID proteins in neoplastic progression of multiple tumor types that often mirrors their function in physiological stem and progenitor cells. ID proteins are required for the maintenance of cancer stem cells, self-renewal, and proliferation in a range of malignancies. Furthermore, ID proteins promote metastatic dissemination through their role in remodeling the tumor microenvironment and by promoting tumor-associated endothelial progenitor cell proliferation and mobilization. Here, we discuss the latest findings in this area and the clinical opportunities that they provide.

UR - http://www.scopus.com/inward/record.url?scp=84905496932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905496932&partnerID=8YFLogxK

U2 - 10.1038/mt.2014.83

DO - 10.1038/mt.2014.83

M3 - Article

VL - 22

SP - 1407

EP - 1415

JO - Molecular therapy : the journal of the American Society of Gene Therapy

T2 - Molecular therapy : the journal of the American Society of Gene Therapy

JF - Molecular therapy : the journal of the American Society of Gene Therapy

SN - 1525-0016

IS - 8

ER -

ID: 3068995